Advisory Committee on the Medical Uses of Isotopes: Meeting Notice, 18655 [2015-07990]
Download as PDF
Federal Register / Vol. 80, No. 66 / Tuesday, April 7, 2015 / Notices
Nominations are due on or
before June 8, 2015.
DATES:
Submit an
electronic copy of resume or curriculum
vitae to Ms. Sophie Holiday,
Sophie.Holiday@nrc.gov. Please ensure
that the resume or curriculum vitae
includes the following information, if
applicable: Education; certification;
professional association membership
and committee membership activities;
duties and responsibilities in current
and previous clinical, research, and/or
academic position(s).
FOR FURTHER INFORMATION CONTACT: Ms.
Sophie Holiday, U.S. Nuclear
Regulatory Commission, Office of
Nuclear Material Safety and Safeguards;
telephone (404) 997–4691; email:
Sophie.Holiday@nrc.gov.
SUPPLEMENTARY INFORMATION: The
ACMUI Nuclear Pharmacist provides
advice on issues associated with the
regulation of nuclear pharmacy
applications of byproduct material. This
advice includes providing input on NRC
proposed rules and guidance, providing
recommendations on the training and
experience requirements for Authorized
Nuclear Pharmacists, identifying
medical events associated with these
uses, evaluating non-routine uses of
byproduct material, bringing key issues
in the nuclear pharmacy community to
the attention of NRC staff, as they relate
to radiopharmaceuticals, radiation
safety and NRC medical-use policy.
ACMUI members are selected based
on their educational background,
certification(s), work experience,
involvement and/or leadership in
professional society activities, and other
information obtained in letters or during
the selection process.
ACMUI members possess the medical
and technical skills needed to address
evolving issues. The current
membership is comprised of the
following professionals: (a) Nuclear
medicine physician; (b) nuclear
cardiologist; (c) two radiation
oncologists; (d) diagnostic radiologist;
(e) therapy medical physicist; (f) nuclear
medicine physicist; (g) nuclear
pharmacist; (h) health care
administrator; (i) radiation safety officer;
(j) patients’ rights advocate; (k) Food
and Drug Administration representative;
and (l) Agreement State representative.
NRC is inviting nominations for the
Nuclear Pharmacist to the ACMUI. The
term of the individual currently
occupying this position will end March
29, 2016. Committee members currently
serve a four-year term and may be
considered for reappointment to an
additional term.
mstockstill on DSK4VPTVN1PROD with NOTICES
NOMINATION PROCESS:
VerDate Sep<11>2014
17:46 Apr 06, 2015
Jkt 235001
Nominees must be U.S. citizens and
be able to devote approximately 160
hours per year to Committee business.
Members who are not Federal
employees are compensated for their
service. In addition, members are
reimbursed for travel (including perdiem in lieu of subsistence) and are
reimbursed secretarial and
correspondence expenses. Full-time
Federal employees are reimbursed travel
expenses only.
Security Background Check: The
selected nominee will undergo a
thorough security background check.
Security paperwork may take the
nominee several weeks to complete.
Nominees will also be required to
complete a financial disclosure
statement to avoid conflicts of interest.
Dated at Rockville, Maryland, this 1st day
of April, 2015.
For the U.S. Nuclear Regulatory
Commission.
Andrew L. Bates,
Advisory Committee Management Officer.
[FR Doc. 2015–07993 Filed 4–6–15; 8:45 am]
BILLING CODE CODE 7590–01–P
NUCLEAR REGULATORY
COMMISSION
Advisory Committee on the Medical
Uses of Isotopes: Meeting Notice
U.S. Nuclear Regulatory
Commission.
ACTION: Notice of meeting.
AGENCY:
The U.S. Nuclear Regulatory
Commission will convene a
teleconference meeting of the Advisory
Committee on the Medical Uses of
Isotopes (ACMUI) on June 16, 2015, to
discuss the ACMUI Radioactive Seed
Localization subcommittee report and to
hear a presentation from Spectrum
Pharmaceuticals regarding the training
and experience requirements for alpha
and beta emitters. Meeting information,
including a copy of the agenda and
handouts, will be available at https://
www.nrc.gov/reading-rm/doccollections/acmui/meetings/2015.html.
The agenda and handouts may also be
obtained by contacting Ms. Sophie
Holiday using the information below.
DATES: The teleconference meeting will
be held on Tuesday, June 16, 2015, 2:00
p.m. to 5:00 p.m. Eastern Standard
Time.
Public Participation: Any member of
the public who wishes to participate in
the teleconference should contact Ms.
Holiday using the contact information
below.
FOR FURTHER INFORMATION CONTACT: Ms.
Sophie Holiday, U.S. Nuclear
SUMMARY:
PO 00000
Frm 00070
Fmt 4703
Sfmt 4703
18655
Regulatory Commission, Office of
Nuclear Material Safety and Safeguards;
telephone: (404) 997–4691, email:
sophie.holiday@nrc.gov.
Conduct of the Meeting
Dr. Bruce Thomadsen, ACMUI
Chairman, will preside over the
meeting. Dr. Thomadsen will conduct
the meeting in a manner that will
facilitate the orderly conduct of
business. The following procedures
apply to public participation in the
meeting:
1. Persons who wish to provide a
written statement should submit an
electronic copy to Ms. Holiday at the
contact information listed above. All
submittals must be received by June 11,
2015, three business days prior to the
meeting, and must pertain to the topic
on the agenda for the meeting.
2. Questions and comments from
members of the public will be permitted
during the meetings, at the discretion of
the Chairman.
3. The draft transcript and meeting
summary will be available on ACMUI’s
Web site https://www.nrc.gov/readingrm/doc-collections/acmui/meetings/
2015.html on or about July 29, 2015.
This meeting will be held in
accordance with the Atomic Energy Act
of 1954, as amended (primarily Section
161a); the Federal Advisory Committee
Act (5 U.S.C. App); and the
Commission’s regulations in Title 10 of
the Code of Federal Regulations Part 7.
Dated at Rockville, Maryland, this 1st day
of April, 2015.
For the U.S. Nuclear Regulatory
Commission.
Andrew L. Bates,
Advisory Committee Management Officer.
[FR Doc. 2015–07990 Filed 4–6–15; 8:45 am]
BILLING CODE CODE 7590–01–P
NUCLEAR REGULATORY
COMMISSION
[NRC–2015–0058]
Applications and Amendments to
Facility Operating Licenses and
Combined Licenses Involving
Proposed No Significant Hazards
Considerations and Containing
Sensitive Unclassified Non-Safeguards
Information and Order Imposing
Procedures for Access to Sensitive
Unclassified Non-Safeguards
Information
Nuclear Regulatory
Commission.
ACTION: License amendment request;
opportunity to comment, request a
AGENCY:
E:\FR\FM\07APN1.SGM
07APN1
Agencies
[Federal Register Volume 80, Number 66 (Tuesday, April 7, 2015)]
[Notices]
[Page 18655]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-07990]
-----------------------------------------------------------------------
NUCLEAR REGULATORY COMMISSION
Advisory Committee on the Medical Uses of Isotopes: Meeting
Notice
AGENCY: U.S. Nuclear Regulatory Commission.
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: The U.S. Nuclear Regulatory Commission will convene a
teleconference meeting of the Advisory Committee on the Medical Uses of
Isotopes (ACMUI) on June 16, 2015, to discuss the ACMUI Radioactive
Seed Localization subcommittee report and to hear a presentation from
Spectrum Pharmaceuticals regarding the training and experience
requirements for alpha and beta emitters. Meeting information,
including a copy of the agenda and handouts, will be available at
https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2015.html.
The agenda and handouts may also be obtained by contacting Ms. Sophie
Holiday using the information below.
DATES: The teleconference meeting will be held on Tuesday, June 16,
2015, 2:00 p.m. to 5:00 p.m. Eastern Standard Time.
Public Participation: Any member of the public who wishes to
participate in the teleconference should contact Ms. Holiday using the
contact information below.
FOR FURTHER INFORMATION CONTACT: Ms. Sophie Holiday, U.S. Nuclear
Regulatory Commission, Office of Nuclear Material Safety and
Safeguards; telephone: (404) 997-4691, email: sophie.holiday@nrc.gov.
Conduct of the Meeting
Dr. Bruce Thomadsen, ACMUI Chairman, will preside over the meeting.
Dr. Thomadsen will conduct the meeting in a manner that will facilitate
the orderly conduct of business. The following procedures apply to
public participation in the meeting:
1. Persons who wish to provide a written statement should submit an
electronic copy to Ms. Holiday at the contact information listed above.
All submittals must be received by June 11, 2015, three business days
prior to the meeting, and must pertain to the topic on the agenda for
the meeting.
2. Questions and comments from members of the public will be
permitted during the meetings, at the discretion of the Chairman.
3. The draft transcript and meeting summary will be available on
ACMUI's Web site https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2015.html on or about July 29, 2015.
This meeting will be held in accordance with the Atomic Energy Act
of 1954, as amended (primarily Section 161a); the Federal Advisory
Committee Act (5 U.S.C. App); and the Commission's regulations in Title
10 of the Code of Federal Regulations Part 7.
Dated at Rockville, Maryland, this 1st day of April, 2015.
For the U.S. Nuclear Regulatory Commission.
Andrew L. Bates,
Advisory Committee Management Officer.
[FR Doc. 2015-07990 Filed 4-6-15; 8:45 am]
BILLING CODE CODE 7590-01-P